Betah D - Search Results

1

Romosozumab Improves Microarchitecture as Assessed by Tissue Thickness-Adjusted Trabecular Bone Score in Postmenopausal Women with Osteoporosis.

McClung MR, Betah D, Leder BZ, Kendler DL, Oates M, Timoshanko J, Wang Z. McClung MR, et al. Among authors: betah d. J Bone Miner Res. 2024 Dec 5:zjae194. doi: 10.1093/jbmr/zjae194. Online ahead of print. J Bone Miner Res. 2024. PMID: 39656908

2

Romosozumab followed by denosumab versus denosumab only: a post hoc analysis of FRAME and FRAME extension.

Cosman F, Oates M, Betah D, Timoshanko J, Wang Z, Ferrari S, McClung MR. Cosman F, et al. Among authors: betah d. J Bone Miner Res. 2024 Sep 2;39(9):1268-1277. doi: 10.1093/jbmr/zjae116. J Bone Miner Res. 2024. PMID: 39041711 Free PMC article. Clinical Trial.

3

Reconstruction of remodeling units reveals positive effects after 2 and 12 months of romosozumab treatment.

Eriksen EF, Boyce RW, Shi Y, Brown JP, Betah D, Libanati C, Oates M, Chapurlat R, Chavassieux P. Eriksen EF, et al. Among authors: betah d. J Bone Miner Res. 2024 Jul 23;39(6):729-736. doi: 10.1093/jbmr/zjae055. J Bone Miner Res. 2024. PMID: 38640512 Clinical Trial.

4

3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate.

Lewiecki EM, Betah D, Humbert L, Libanati C, Oates M, Shi Y, Winzenrieth R, Ferrari S, Omura F. Lewiecki EM, et al. Among authors: betah d. J Bone Miner Res. 2024 May 2;39(4):473-483. doi: 10.1093/jbmr/zjae028. J Bone Miner Res. 2024. PMID: 38477808 Free PMC article. Clinical Trial.

5

Effect of Romosozumab Treatment in Postmenopausal Women With Osteoporosis and Knee Osteoarthritis: Results From a Substudy of a Phase 3 Clinical Trial.

Lane NE, Betah D, Deignan C, Oates M, Wang Z, Timoshanko J, Khan AA, Binkley N. Lane NE, et al. Among authors: betah d. ACR Open Rheumatol. 2024 Jan;6(1):43-51. doi: 10.1002/acr2.11619. Epub 2023 Nov 20. ACR Open Rheumatol. 2024. PMID: 37985218 Free PMC article.

6

Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk.

McClung MR, Betah D, Deignan C, Shi Y, Timoshanko J, Cosman F. McClung MR, et al. Among authors: betah d. Endocr Pract. 2023 Sep;29(9):716-722. doi: 10.1016/j.eprac.2023.06.011. Epub 2023 Jul 4. Endocr Pract. 2023. PMID: 37406858 Free article.

7

Modeling-Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial.

Eriksen EF, Chapurlat R, Boyce RW, Shi Y, Brown JP, Horlait S, Betah D, Libanati C, Chavassieux P. Eriksen EF, et al. Among authors: betah d. J Bone Miner Res. 2022 Jan;37(1):36-40. doi: 10.1002/jbmr.4457. Epub 2021 Nov 19. J Bone Miner Res. 2022. PMID: 34633116 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters